Uncategorized
Aerie Pharmaceuticals Announces Appointment of Richard A. Halprin as Director of Professional Affairs
IRVINE, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced the appointment of Richard (Rick) A. Halprin as Director of Professional Affairs, reporting to Theresa Heah, M.D., M.B.A., Aerie’s Vice President of Clinical Research and Medical Affairs. Mr. Halprin will be responsibl